annual EBITDA:
$233.41M+$11.90M(+5.37%)Summary
- As of today (June 26, 2025), HRMY annual EBITDA is $233.41 million, with the most recent change of +$11.90 million (+5.37%) on December 31, 2024.
- During the last 3 years, HRMY annual EBITDA has risen by +$152.95 million (+190.09%).
- HRMY annual EBITDA is now at all-time high.
Performance
HRMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$66.98M+$649.00K(+0.98%)Summary
- As of today (June 26, 2025), HRMY quarterly EBITDA is $66.98 million, with the most recent change of +$649.00 thousand (+0.98%) on March 31, 2025.
- Over the past year, HRMY quarterly EBITDA has increased by +$4.54 million (+7.27%).
- HRMY quarterly EBITDA is now -7.59% below its all-time high of $72.49 million, reached on September 30, 2024.
Performance
HRMY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$237.95M+$4.54M(+1.94%)Summary
- As of today (June 26, 2025), HRMY TTM EBITDA is $237.95 million, with the most recent change of +$4.54 million (+1.94%) on March 31, 2025.
- Over the past year, HRMY TTM EBITDA has increased by +$3.57 million (+1.52%).
- HRMY TTM EBITDA is now at all-time high.
Performance
HRMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HRMY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | +7.3% | +1.5% |
| 3 y3 years | +190.1% | +104.5% | +153.1% |
| 5 y5 years | +263.6% | +967.0% | +372.4% |
HRMY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +190.1% | -7.6% | +271.7% | at high | +153.1% |
| 5 y | 5-year | at high | +263.6% | -7.6% | +593.6% | at high | +372.4% |
| alltime | all time | at high | +263.6% | -7.6% | +206.2% | at high | +266.8% |
HRMY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $66.98M(+1.0%) | $237.95M(+1.9%) |
| Dec 2024 | $233.41M(+5.4%) | $66.33M(-8.5%) | $233.41M(+7.2%) |
| Sep 2024 | - | $72.49M(+125.5%) | $217.69M(+3.6%) |
| Jun 2024 | - | $32.15M(-48.5%) | $210.15M(-10.3%) |
| Mar 2024 | - | $62.44M(+23.4%) | $234.38M(+5.8%) |
| Dec 2023 | $221.51M(+50.8%) | $50.61M(-22.1%) | $221.51M(-2.8%) |
| Sep 2023 | - | $64.95M(+15.2%) | $227.78M(+25.9%) |
| Jun 2023 | - | $56.38M(+13.7%) | $180.85M(+10.5%) |
| Mar 2023 | - | $49.58M(-12.8%) | $163.69M(+11.5%) |
| Dec 2022 | $146.87M(+82.5%) | $56.88M(+215.6%) | $146.87M(+18.8%) |
| Sep 2022 | - | $18.02M(-54.0%) | $123.63M(+17.5%) |
| Jun 2022 | - | $39.21M(+19.7%) | $105.19M(+11.9%) |
| Mar 2022 | - | $32.75M(-2.7%) | $94.02M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $80.46M(+5218.0%) | $33.65M(-8091.9%) | $80.46M(+142.0%) |
| Sep 2021 | - | -$421.00K(-101.5%) | $33.25M(-27.7%) |
| Jun 2021 | - | $28.05M(+46.1%) | $46.02M(+68.7%) |
| Mar 2021 | - | $19.19M(-241.4%) | $27.28M(+7374.8%) |
| Dec 2020 | $1.51M(-101.1%) | -$13.57M(-209.9%) | $365.00K(-102.0%) |
| Sep 2020 | - | $12.35M(+32.6%) | -$17.81M(-69.8%) |
| Jun 2020 | - | $9.31M(-220.5%) | -$58.91M(-32.6%) |
| Mar 2020 | - | -$7.73M(-75.7%) | -$87.36M(-38.8%) |
| Dec 2019 | -$142.69M(+245.9%) | -$31.75M(+10.4%) | -$142.69M(+28.6%) |
| Sep 2019 | - | -$28.75M(+50.2%) | -$110.94M(+35.0%) |
| Jun 2019 | - | -$19.14M(-69.6%) | -$82.19M(+30.4%) |
| Mar 2019 | - | -$63.05M | -$63.05M |
| Dec 2018 | -$41.26M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual EBITDA?
- What is the all time high annual EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual EBITDA year-on-year change?
- What is Harmony Biosciences Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly EBITDA year-on-year change?
- What is Harmony Biosciences Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM EBITDA year-on-year change?
What is Harmony Biosciences Holdings annual EBITDA?
The current annual EBITDA of HRMY is $233.41M
What is the all time high annual EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual EBITDA is $233.41M
What is Harmony Biosciences Holdings annual EBITDA year-on-year change?
Over the past year, HRMY annual EBITDA has changed by +$11.90M (+5.37%)
What is Harmony Biosciences Holdings quarterly EBITDA?
The current quarterly EBITDA of HRMY is $66.98M
What is the all time high quarterly EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly EBITDA is $72.49M
What is Harmony Biosciences Holdings quarterly EBITDA year-on-year change?
Over the past year, HRMY quarterly EBITDA has changed by +$4.54M (+7.27%)
What is Harmony Biosciences Holdings TTM EBITDA?
The current TTM EBITDA of HRMY is $237.95M
What is the all time high TTM EBITDA for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM EBITDA is $237.95M
What is Harmony Biosciences Holdings TTM EBITDA year-on-year change?
Over the past year, HRMY TTM EBITDA has changed by +$3.57M (+1.52%)